New COVID-19 open data from Austria
At the end of December 2021, the European Medical Association
authorised the use of the protein-based Nuvaxovid vaccine. With
shipments arriving in Member States, open-data portals have started to
track their distribution and use.

In Austria, on 1 March 2022, the Austrian Open Data Portal
[https://www.data.gv.at/] updated their open data files to include
information about Nuvaxovid. This data, published as a CSV file
[https://info.gesundheitsministerium.gv.at/data/COVID19_vaccination_doses_agegroups.csv],
includes COVID-19 vaccine doses administered by age and gender,
divided by province, for all approved vaccines.

Various government-run dashboards at a national and regional level use
open data to visualise the situation with COVID-19, including the
COVID-19 dashboard for the western most province of Voralberg
[https://impfung.lwz-vorarlberg.at/grafana/d/Mb63P5O7k/impfquote-vollimmunisierte-vorarlberg-gesamt?orgId=1&from=now-60d&to=now&refresh=5m&kiosk].
Their dashboard shows, at a glance, the number of people vaccinated
and with how many doses.

Looking for more news and events? Follow us on Twitter
[https://twitter.com/EU_opendata], Facebook
[https://www.facebook.com/data.europa.eu], and LinkedIn
[https://www.linkedin.com/company/publications-office-of-the-european-union/],
or subscribe to our newsletter
[https://data.europa.eu/en/newsletter].

Publication Date/Time
2022-03-21T14:00:35+00:00
Adding information about distribution of the Nuvaxovid vaccine